Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › BIO

DEERFIELD MANAGEMENT COMPANY, L.P. position in BIO

BIO RAD LABS INC CL A · Industrials

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 226,070 shares of BIO (BIO RAD LABS INC CL A) in its Q2 2026 13F filing — a position valued at US$66.4M, representing 0.83% of its reported portfolio and ranking #34 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed BIO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)226.07K sh
Reported value held$66.38M
Portfolio Weight0.83%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s BIO position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in BIO in Q3 2023 at 173,947 shares (US$62.4M). The position peaked in Q4 2025 at 226,070 shares, worth US$68.5M. Across 12 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 226,070 shares valued at US$66.4M. Notable position changes include a 49% increase in Q1 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 173.95K $62.35M New
Q4 2023 151.57K $48.94M Reduce
Q1 2024 152.38K $52.70M Add
Q2 2024 151.71K $41.43M Hold
Q3 2024 151.57K $50.71M Hold
Q4 2024 151.64K $49.82M Hold
Q1 2025 226.07K $55.06M Add
Q2 2025 226.07K $54.56M Hold
Q3 2025 226.07K $63.39M Hold
Q4 2025 226.07K $68.50M Hold
Q1 2026 226.07K $63.02M Hold
Q2 2026 226.07K $66.38M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIO and 13F data

BIO (BIO RAD LABS INC CL A) is a Industrials company. 22 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$765.2M), ARIEL INVESTMENTS, LLC (US$239.8M), First Pacific Advisors, LP (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIO

All BIO fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held BIO?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed BIO holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in BIO?

As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 226.07K shares of BIO (BIO RAD LABS INC CL A), valued at $66.38M, representing 0.83% of its reported portfolio and ranking #34.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling BIO?

In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. held unchanged its position in BIO. The position peaked in Q4 2025 at 226.07K shares.

Which other funds hold BIO?

Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, First Pacific Advisors, LP, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.